Improved blood test offers less invasive way to detect Alzheimer’s disease

A new study in Nature Aging from Lund University in Sweden shows that improved blood tests for the diagnosis of Alzheimer's disease can now be used with accuracy similar to that of the cerebrospinal fluid tests that have long been the standard in health care.

“These new findings are based on cutoff values that directly reflect clinical practice. The results show that this improved blood test, which has previously received FDA approval and CE marking for clinical use, is just as accurate as the established cerebrospinal fluid test—detecting Alzheimer’s disease pathology with at least 90% accuracy.

“It is the first time this has been demonstrated,” says Noëlle Warmenhoven, a doctoral student in the Clinical Memory Research Unit at Lund University.

Sign up for Blog Updates